Aclaris Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACRS and other ETFs, options, and stocks.About ACRS
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments.
CEONeal S. Walker
CEONeal S. Walker
Employees64
Employees64
HeadquartersWayne, Pennsylvania
HeadquartersWayne, Pennsylvania
Founded2012
Founded2012
Employees64
Employees64
ACRS Key Statistics
Market cap326.66M
Market cap326.66M
Price-Earnings ratio-2.18
Price-Earnings ratio-2.18
Dividend yield—
Dividend yield—
Average volume1.16M
Average volume1.16M
High today$3.08
High today$3.08
Low today$2.73
Low today$2.73
Open price$2.75
Open price$2.75
Volume1.62M
Volume1.62M
52 Week high$4.03
52 Week high$4.03
52 Week low$1.05
52 Week low$1.05
Stock Snapshot
Aclaris Therapeutics(ACRS) stock is priced at $3.01, giving the company a market capitalization of 326.66M. It carries a P/E multiple of -2.18.
As of 2025-12-04, Aclaris Therapeutics(ACRS) stock has fluctuated between $2.73 and $3.08. The current price stands at $3.01, placing the stock +10.3% above today's low and -2.1% off the high.
Aclaris Therapeutics(ACRS) shares are trading with a volume of 1.62M, against a daily average of 1.16M.
In the last year, Aclaris Therapeutics(ACRS) shares hit a 52-week high of $4.03 and a 52-week low of $1.05.
In the last year, Aclaris Therapeutics(ACRS) shares hit a 52-week high of $4.03 and a 52-week low of $1.05.
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own ACRS. This list is generated using Robinhood data, and it’s not a recommendation.